Option chain shows key data for RenovoRx's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for RenovoRx.

RenovoRx (NASDAQ:RNXT) Stock, Option Chain

RenovoRx

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Stock market analysts

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ARMK

DCBO

EXAS

RNXT

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday

movers image

Intraday Update

Movers

ADBE

BAND

BIMI

CABA

CANF

CNSP

CORT

FOXO

GANX

INAB

IONM

IRON

JFBR

KAVL

KITT

KYTX

LGVN

NAAS

NNVC

NVAX

OCUL

ONMD

PENN

POWW

RARE

RZLT

SVMH

THMO

TWOU

WLFC

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Penny Stocks

Small Cap

ADTX

ALLO

AMPX

AOSL

ARBK

AVXL

BROG

BTCS

BTDR

CLSK

DOGZ

GDRX

HLTH

KNSA

KORE

LBPH

LMDX

LYEL

MARA

MNKD

MOBX

MRNA

MSTR

PGEN

PRTC

RIOT

RIVN

SNES

SNGX

SNTG

SXTC

TBLT

VSTE

VTNR

VYGR

Shares of  Longboard Pharmaceuticals, Inc.

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

RenovoRx Inc

Press Releases

RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting

RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting

RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th

RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community

Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx's Ongoing Phase III TIGeR-PaC Clinical Trial

RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET

U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform

RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st

RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights

Adicet Bio

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Aligos Therapeutics

Annovis Bio

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

Avalo Therapeutics

Celularity

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Fortress Biotech

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

MAIA Biotechnology

Mural Oncology

OS Therapies

PepGen

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Senti Biosciences

Shattuck Labs

Ascendiant Capital

HC Wainwright & Co.

Alliance Global Partners

Roth MKM

Comments

RenovoRx

RenovoRx (RNXT) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell